Cite
APA Citation
Tapia, C., Aung, P. P., Roy-Chowdhuri, S., Xu, M., Ouyang, F., Alshawa, A., Hajjar, J., Singh, G., Yang, V., Castillo, L., Le, H., Murthy, R., Stephen, B., Hess, K. R., Wistuba, I., & Naing, A. (2020). decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors. Journal for immunotherapy of cancer, 8(1), . http://access.bl.uk/ark:/81055/vdc_100127562260.0x000031